<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; AIMS: Mutational inactivation of <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) is an early event in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) progression that affects the stability and increases the activity of β-catenin, a mediator of Wnt signaling </plain></SENT>
<SENT sid="1" pm="."><plain>Progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> also involves inactivation of signaling via transforming growth factor β and bone morphogenetic protein (BMP), which are <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors </plain></SENT>
<SENT sid="2" pm="."><plain>However, the interactions between these pathways are not clear </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated the effects of loss of the transcription factor Smad4 on levels of β-catenin <z:chebi fb="5" ids="33699">messenger RNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) and Wnt signaling </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We used microarray analysis to associate levels of Smad4 and β-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi> in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> samples from 250 patients </plain></SENT>
<SENT sid="5" pm="."><plain>We performed oligonucleotide-mediated knockdown of Smad4 in human embryonic kidney (HEK293T) and in HCT116 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells and transgenically expressed Smad4 in SW480 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells </plain></SENT>
<SENT sid="6" pm="."><plain>We analyzed <z:mpath ids='MPATH_270'>adenomas</z:mpath> from (APC(Δ1638/+)) and (APC(Δ1638/+)) × (K19Cre(ERT2)Smad4(lox/lox)) mice by using laser capture microdissection </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: In human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples, reduced levels of Smad4 correlated with increased levels of β-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>In Smad4-depleted cell lines, levels of β-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and Wnt signaling increased </plain></SENT>
<SENT sid="9" pm="."><plain>Inhibition of BMP or <z:mpath ids='MPATH_63'>depletion</z:mpath> of Smad4 in HEK293T cells increased binding of <z:chebi fb="40" ids="33697">RNA</z:chebi> polymerase II to the β-catenin gene </plain></SENT>
<SENT sid="10" pm="."><plain>Expression of Smad4 in SW480 cells reduced Wnt signaling and levels of β-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>In mice with heterozygous disruption of Apc(APC(Δ1638/+)), Smad4-deficient intestinal <z:mpath ids='MPATH_270'>adenomas</z:mpath> had increased levels of β-catenin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and expression of Wnt target genes compared with <z:mpath ids='MPATH_270'>adenomas</z:mpath> from APC(Δ1638/+) mice that expressed Smad4 </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Transcription of β-catenin is inhibited by BMP signaling to Smad4 </plain></SENT>
<SENT sid="13" pm="."><plain>These findings provide important information about the interaction among transforming growth factor β, BMP, and Wnt signaling pathways in progression of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>